US Patent 10183024 Crystalline forms of ibrutinib
Patent 10183024 was granted and assigned to Apotex on January, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10183024 Crystalline forms of ibrutinib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.